Anti-snoring treatment market is expected to witness positive growth during the forecast period. Snoring is a common condition occurs in anyone, more frequently in men and people who are overweight. Snoring not only disrupt the sleep patterns of others, but also weaker sleep quality of the person. Snoring has the tendency to rise due to increasing age. The habitual snoring can be a sign of serious health problems and obstructive sleep apnea such as Interruptions of breathing, frequent waking from sleep, light sleeping, the strain on the heart, and poor night sleep. The globally rising number of obese people due to changing lifestyle and unhealthy dietary habits such as consumption of alcohol, tobacco, and smoking is triggering the growth of anti-snoring treatment industry.
Browse the full report of "Anti-Snoring Treatment Market - Global Industry Share, Growth, Competitive Analysis and Forecast, 2019-2025" at https://www.omrglobal.com/industry-reports/anti-snoring-treatment-market
According to the National Sleep Foundation, snoring affects around 90 million adults in the US and 37 million on a regular basis. Growing anatomical abnormalities of throat and nose including enlarged tonsils and deviated nasal results in narrowing of the throat during sleep; that raises the high demand for anti-snoring treatment devices. The anti-snoring devices include mandibular advancement devices, nasal devices, and continuous positive airway pressure (CPAP) devices. Mandibular advancement devices prevent users from snoring and help those who grind teeth during sleep. While nasal devices blow air through a nose mask and help in keeping the airway open while sleeping through air compressor machine.
First "Dual Action" Over the Counter (OTC) 510k Clearance from the FDA
In March 2019, Zyppah announced that after six years on the market, Zyppah Anti-Snoring Device has become the first marketed anti-snoring device and has been granted the necessary clearances by the FDA to be made available OTC. Zyppah's certification included a "first" ranking when compared against the category monograph to feature a wholly unique, dual-action feature that advances the mandible while repositioning the tongue to keep it from blocking the airway. As noted in the certification Zyppah is intended for use by adults as an aid to reduce snoring.
For more customized data, request report customization @ https://www.omrglobal.com/report-customization/anti-snoring-treatment-market
Primark Launch Anti-Snore Pillow
In February 2019, Primark launched anti-snore pillow for assisting patients in preventing snoring during sleep. The pillow is cost-effective than other anti-snoring pillows available in the market. The company aims to meet the growing demand of consumers for less expensive anti-snoring products with an aim to expand its customer base as well as elevate its anti-snoring product sales.
Segmentation Analysis of the Industry
Global anti-snoring treatment market can be segmented on the basis of device, and surgery. According to the device, the market is further diversified as mandibular advancement devices, nasal devices, continuous positive airway pressure devices, and others. Among devices, continuous positive airway pressure (CPAP) devices segment is anticipated to hold the significant share as it is the most commonly used treatment among children and adults.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/anti-snoring-treatment-market
Geographically, the market is divided into North America, Europe, Asia-Pacific and Rest of the World. North America region is growing with significant growth and is expected to contribute considerably to the global anti-snoring treatment market owing to increasing demand from sleep apnea patients in the region.
Industry Key Players
There are various companies that are involved in the global anti-snoring treatment market such as Medtronic PLC, Invacare Corp., Koninklijke Philips NV, Oventus Medical Ltd., ResMed Inc., and others. To stay competitive in the market, the players in the market adopt various strategies such as partnership and collaboration, and product launch. For instance, ResMed Inc., in May 2017, launched AirTouch F20 full face mask for patients on CPAP therapy for sleep apnea.
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Contact no: +1 646-755-7667, +91 7803040404
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com